TY - JOUR T1 - DNA Repair Gene <em>ERCC2, XPC, XRCC1, XRCC3</em> Polymorphisms and Associations with Bladder Cancer Risk in a French Cohort JF - Anticancer Research JO - Anticancer Res SP - 1853 LP - 1856 VL - 28 IS - 3B AU - LUC FONTANA AU - RÉMY BOSVIEL AU - LAETITIA DELORT AU - LAURENT GUY AU - NASSÉRA CHALABI AU - FABRICE KWIATKOWSKI AU - SAMIR SATIH AU - NADÈGE RABIAU AU - JEAN-PAUL BOITEUX AU - ALAIN CHAMOUX AU - YVES-JEAN BIGNON AU - DOMINIQUE J. BERNARD-GALLON Y1 - 2008/05/01 UR - http://ar.iiarjournals.org/content/28/3B/1853.abstract N2 - In polygenic diseases, association studies look for genetic variation such as polymorphisms in low penetrance genes, i.e. genes in interaction with environmental factors. DNA repair systems that protect the genome from deleterious endogenous and exogenous damage have been shown to significantly reduce activity. In particular, enzymes of the nucleotide excision repair pathway are suspected to be implicated in cancer. In this study bladder cancer which is viewed as a polygenic disease was investigated. The functional polymorphisms of four DNA repair genes, excision repair cross-complementing group 2 (ERCC2), Xeroderma Pigmentosum group C (XPC), and X-ray repair cross-complementing groups 1 and 3 (XRCC1 and XRCC3) were analyzed. The studied population included 51 bladder cancer cases and 45 controls. The genotyping of six SNP (single nucleotide polymorphism) was carried out on these populations with the MGB (Minor Groove Binder) probe technique which uses allelic discrimination with the Taqman® method. The Gln allele of the XPC 939 polymorphism was found to be associated with an increase in bladder cancer risk. Copyright© 2008 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved ER -